CWRU spinout AlensiaXR raises $3 million in Series A funding

“The Series A funding will be used to enhance HoloAnatomy® capabilities and advance development efforts to include any field that requires a fundamental understanding of human anatomy, such as dentistry, physiology and pathology,” AlensiaXR CEO Mark Day said. “We are actively engaging our growing customer base to guide the evolution of this pioneering learning platform and will seek to expand into additional applications and global markets.”

Those could include opportunities outside of traditional institutions of higher education. “With the rapid growth in the academic market, we’ve started to see interest in government and commercial markets,” Day said. “We see no limit to the upside of the potential of this extraordinary, immersive learning platform."